Brief: Australian Clinical Labs Says Michael Alscher Will Return To His Role As Chair Of Company
12/09/2023 24:15
Sept 12 (Reuters) - Australian Clinical Labs Ltd
ACL.AX :
* MICHAEL ALSCHER WILL RETURN TO HIS ROLE AS CHAIR OF
COMPANY
* DAREN MCKENNAY WILL CEASE TO BE ACTING CHAIR
Source text for Eikon: ID:nASX7P6RYM
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million